Perspectives
Osteoporosis Management Strategies in the COVID-19 Pandemic
Abstract
Coronavirus disease 2019 (COVID-19) has led to active infections and relatively high morbidity and mortality across the world, including the United States.1 The pandemic has challenged the US healthcare system, and rapid treatment adaptations have had to be made to stabilize public health and provide effective medical care.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.